Atkinson MA, Warady BA (2018) Anemia in chronic kidney disease. Pediatr Nephrol 33:227–238
Atkinson MA, Furth SL (2011) Anemia in children with chronic kidney disease. Nat Rev Nephrol 7:635–641
Gerson A, Hwang W, Fiorenza J, Barth K, Kaskel F, Weiss L, Zelikovsky N, Fivush B, Furth S (2004) Anemia and health-related quality of life in adolescents with chronic kidney disease. Am J Kidney Dis 44:1017–1023
Surkan PJ, Charles MK, Katz J, Siegel EH, Khatry SK, LeClerq SC, Stoltzfus RJ, Tielsch JM (2015) The role of zinc and iron-folic acid supplementation on early child temperament and eating behaviors in rural Nepal: a randomized controlled trial. PLoS One 10:e0114266
Ghrayeb H, Elias M, Nashashibi J, Youssef A, Manal M, Mahagna L, Refaat M, Schwartz N, Elias A (2020) Appetite and ghrelin levels in iron deficiency anemia and the effect of parenteral iron therapy: a longitudinal study. PLoS One 15:e0234209
Zia A, Stanek J, Christian-Rancy M, Savelli S, O’Brien SH (2022) Iron deficiency and fatigue among adolescents with bleeding disorders. Am J Hematol 97:60–67
Nelson M, Bakaliou F, Trivedi A (1994) Iron-deficiency anaemia and physical performance in adolescent girls from different ethnic backgrounds. Br J Nutr 72:427–433
Lee KH, Park E, Choi HJ, Kang HG, Ha IS, Cheong HI, Park YS, Cho H, Han KH, Kim SH, Cho MH, Lee JH, Shin JI (2019) Anemia and iron deficiency in children with chronic kidney disease (CKD): data from the Know-Ped CKD Study. J Clin Med 8:152
Akchurin OM (2019) Chronic kidney disease and dietary measures to improve outcomes. Pediatr Clin North Am 66:247–267
McMurray J, Parfrey P, Adamson JW, Aljama P, Berns JS, Bohlius J, Drüeke TB, Finkelstein FO, Fishbane S, Ganz T (2012) Kidney disease: improving global outcomes (KDIGO) anemia work group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl 2:279–335
Macdougall IC, Bircher AJ, Eckardt K-U, Obrador GT, Pollock CA, Stenvinkel P, Swinkels DW, Wanner C, Weiss G, Chertow GM (2016) Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference. Kidney Int 89:28–39
Sazawal S, Black RE, Ramsan M, Chwaya HM, Stoltzfus RJ, Dutta A, Dhingra U, Kabole I, Deb S, Othman MK (2006) Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 367:133–143
Soofi S, Cousens S, Iqbal SP, Akhund T, Khan J, Ahmed I, Zaidi AKM, Bhutta ZA (2013) Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: a cluster-randomised trial. Lancet 382:29–40
Paul S, Shrestha P, Sumida K, Thomas F, Surbhi S, Naser AM, Streja E, Rhee CM, Kalantar-Zadeh K, Kovesdy CP (2023) Association of oral iron replacement therapy with kidney failure and mortality in CKD patients. Clin Kidney J 16:2082–2090
Gutiérrez OM (2021) Treatment of iron deficiency anemia in CKD and end-stage kidney disease. Kidney Int Rep 6:2261–2269
Meza K, Biswas S, Talmor C, Baqai K, Samsonov D, Solomon S, Akchurin O (2024) Response to oral iron therapy in children with anemia of chronic kidney disease. Pediatr Nephrol 39:233–242
Akchurin O, Molino AR, Schneider MF, Atkinson MA, Warady BA, Furth SL (2023) Longitudinal relationship between anemia and statural growth impairment in children and adolescents with nonglomerular CKD: findings from the chronic kidney disease in children (CKiD) study. Am J Kidney Dis 81:457–65.e1
Kliger AS, Foley RN, Goldfarb DS, Goldstein SL, Johansen K, Singh A, Szczech L (2013) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for anemia in CKD. Am J Kidney Dis 62:849–859
Irwin DE, Gross HE, Stucky BD, Thissen D, DeWitt EM, Lai JS, Amtmann D, Khastou L, Varni JW, DeWalt DA (2012) Development of six PROMIS pediatrics proxy-report item banks. Health Qual Life Outcomes 10:22
Tucker CA, Bevans KB, Teneralli RE, Smith AW, Bowles HR, Forrest CB (2014) Self-reported pediatric measures of physical activity, sedentary behavior, and strength impact for PROMIS: conceptual framework. Pediatr Phys Ther 26:376–384
Tucker CA, Bevans KB, Teneralli RE, Smith AW, Bowles HR, Forrest CB (2014) Self-reported pediatric measures of physical activity, sedentary behavior, and strength impact for PROMIS: item development. Pediatr Phys Ther 26:385–392
Akchurin OM, Schneider MF, Mulqueen L, Brooks ER, Langman CB, Greenbaum LA, Furth SL, Moxey-Mims M, Warady BA, Kaskel FJ, Skversky AL (2014) Medication adherence and growth in children with CKD. Clin J Am Soc Nephrol 9:1519–1525
Babitt JL, Eisenga MF, Haase VH, Kshirsagar AV, Levin A, Locatelli F, Małyszko J, Swinkels DW, Tarng D-C, Cheung M (2021) Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference. Kidney Int 99:1280–1295
Tolkien Z, Stecher L, Mander AP, Pereira DIA, Powell JJ (2015) Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One 10:e0117383
Kortman GAM, Reijnders D, Swinkels DW (2017) Oral iron supplementation: Potential implications for the gut microbiome and metabolome in patients with CKD. Hemodial Int 21:S28–S36
Dewey KG, Cohen RJ, Lönnerdal B, Domellöf M, Rivera LL, Hernell O (2002) Iron supplementation affects growth and morbidity of breast-fed infants: results of a randomized trial in Sweden and Honduras. J Nutr 132:3249–3255
Perng W, Mora-Plazas M, Marin C, Villamor E (2013) Iron status and linear growth: a prospective study in school-age children. Eur J Clin Nutr 67:646–651
Patino E, Doty SB, Bhatia D, Meza K, Zhu YS, Rivella S, Choi ME, Akchurin O (2020) Carbonyl iron and iron dextran therapies cause adverse effects on bone health in juveniles with chronic kidney disease. Kidney Int 98:1210–1224
Oboshi M, Naito Y, Sawada H, Iwasaku T, Okuhara Y, Eguchi A, Hirotani S, Mano T, Tsujino T, Masuyama T (2016) Attenuation of hypertension and renal damage in renovascular hypertensive rats by iron restriction. Hypertens Res 39:832–839
Hanudel MR, Chua K, Rappaport M, Gabayan V, Valore E, Goltzman D, Ganz T, Nemeth E, Salusky IB (2016) Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice. Am J Physiol Renal Physiol 311:F1369–F1377
van Swelm RPL, Beurskens S, Dijkman H, Wiegerinck ETG, Roelofs R, Thévenod F, van der Vlag J, Wetzels JFM, Swinkels DW, Smeets B (2022) Kidney tubule iron loading in experimental focal segmental glomerulosclerosis. Sci Rep 12:1199
Feng Y, Jia L, Ma W, Tian C, Du H (2023) Iron chelator deferoxamine alleviates progression of diabetic nephropathy by relieving inflammation and fibrosis in rats. Biomolecules 13:1266
Rajapurkar MM, Hegde U, Bhattacharya A, Alam MG, Shah SV (2013) Effect of deferiprone, an oral iron chelator, in diabetic and non-diabetic glomerular disease. Toxicol Mech Methods 23:5–10
Guan Y, Liang X, Ma Z, Hu H, Liu H, Miao Z, Linkermann A, Hellwege JN, Voight BF, Susztak K (2021) A single genetic locus controls both expression of DPEP1/CHMP1A and kidney disease development via ferroptosis. Nat Commun 12:5078
Arsiwala T, Afroz N, Kordy K, Naujoks C, Patalano F (2021) Measuring what matters for children: a systematic review of frequently used pediatric generic PRO instruments. Ther Innov Regul Sci 55:1082–1095
Prochaska MT, Huisingh-Scheetz M, Meltzer D (2022) Sex differences in fatigue and symptoms of anemia in relation to hemoglobin level in hospitalized patients. Ann Hematol 101:1873–1875
Farag YMK, Blasco-Colmenares E, Zhao D, Sanon M, Guallar E, Finkelstein FO (2023) Effect of anemia on physical function and physical activity in CKD: The National Health and Nutrition Examination Survey, 1999–2016. Kidney360 4:e1212
Odden MC, Whooley MA, Shlipak MG (2004) Association of chronic kidney disease and anemia with physical capacity: the heart and soul study. J Am Soc Nephrol 15:2908–2915
Carlson J, Gerson AC, Matheson MB, Manne S, Warady BA, Hooper SR, Lande M, Harshman LA, Johnson RJ, Shinnar S (2020) A longitudinal analysis of the effect of anemia on health-related quality of life in children with mild-to-moderate chronic kidney disease. Pediatr Nephrol 35:1659–1667
Penninx BWJH, Pahor M, Cesari M, Corsi AM, Woodman RC, Bandinelli S, Guralnik JM, Ferrucci L (2004) Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc 52:719–724
Vinke JSJ, Wouters HJCM, Stam SP, Douwes RM, Post A, Gomes‐Neto AW, van der Klauw MM, Berger SP, Bakker SJL; TransplantLines Investigators; De Borst MH, Eisenga MF (2022) Decreased haemoglobin levels are associated with lower muscle mass and strength in kidney transplant recipients. J Cachexia Sarcopenia Muscle 13:2044–2053
Sypes EE, Parkin PC, Birken CS, Carsley S, MacArthur C, Maguire JL, Borkhoff CM, Aglipay M, Anderson LN, Dai DWH (2019) Higher body mass index is associated with iron deficiency in children 1 to 3 years of age. J Pediatr 207:198–204
Borgna-Pignatti C, Zanella S (2016) Pica as a manifestation of iron deficiency. Expert Rev Hematol 9:1075–1080
Ganesan PR, Vasauskas AA (2023) The association between pica and iron-deficiency anemia: a scoping review. Cureus 15:e37904
Kucuk N, Orbak Z, Karakelloglu C, Akcay F (2019) The effect of therapy on plasma ghrelin and leptin levels, and appetite in children with iron deficiency anemia. J Pediatr Endocrinol Metab 32:275–280
Powers JM, Buchanan GR, Adix L, Zhang S, Gao A, McCavit TL (2017) Effect of low-dose ferrous sulfate vs iron polysaccharide complex on hemoglobin concentration in young children with nutritional iron-deficiency anemia: a randomized clinical trial. JAMA 317:2297–2304
Macdougall IC, Bock AH, Carrera F, Eckardt K-U, Gaillard C, Van Wyck D, Meier Y, Larroque S, Perrin A, Roger SD (2017) Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial. Clin Nephrol 88:301
Akchurin O, Patino E, Dalal V, Meza K, Bhatia D, Brovender S, Zhu YS, Cunningham-Rundles S, Perelstein E, Kumar J, Rivella S, Choi ME (2019) Interleukin-6 contributes to the development of anemia in juvenile CKD. Kidney Int Rep 4:470–483
Comments (0)